Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Acanthamoeba and bacteria produce antimicrobials to target their counterpart.

Iqbal J, Siddiqui R, Khan NA.

Parasit Vectors. 2014 Jan 30;7:56. doi: 10.1186/1756-3305-7-56.

3.

In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.

Sheng WH, Wang JT, Chen YC, Chang SC, Luh KT.

J Microbiol Immunol Infect. 2001 Sep;34(3):178-84.

PMID:
11605808
4.

Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2-yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus.

Al-Qawasmeh RA, Huesca M, Nedunuri V, Peralta R, Wright J, Lee Y, Young A.

Bioorg Med Chem Lett. 2010 Jun 15;20(12):3518-20. doi: 10.1016/j.bmcl.2010.04.137. Epub 2010 May 17.

PMID:
20483613
5.

Antimicrobial activity of selected plant species from "the Argentine Puna" against sensitive and multi-resistant bacteria.

Zampini IC, Cuello S, Alberto MR, OrdoƱez RM, D' Almeida R, Solorzano E, Isla MI.

J Ethnopharmacol. 2009 Jul 30;124(3):499-505. doi: 10.1016/j.jep.2009.05.011. Epub 2009 May 23.

PMID:
19467313
6.

Role of antibiofilm-antimicrobial agents in controlling device-related infections.

Aslam S, Darouiche RO.

Int J Artif Organs. 2011 Sep;34(9):752-8. doi: 10.5301/ijao.5000024.

7.

In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates.

Tanaka M, Yamazaki E, Chiba M, Yoshihara K, Akasaka T, Takemura M, Sato K.

Antimicrob Agents Chemother. 2002 Mar;46(3):904-8.

8.

Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010.

Liu JW, Ko WC, Huang CH, Liao CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Chen YH, Lu PL, Sun W, Wang LS, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR.

Antimicrob Agents Chemother. 2012 Mar;56(3):1414-7. doi: 10.1128/AAC.05879-11. Epub 2011 Dec 12.

9.

Antimicrobial activity of DV-7751a, a new fluoroquinolone.

Tanaka M, Hoshino K, Ishida H, Sato K, Hayakawa I, Osada Y.

Antimicrob Agents Chemother. 1993 Oct;37(10):2112-8.

10.

In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients.

Rolston KV, Ho DH, LeBlanc B, Bodey GP.

Chemotherapy. 1990;36(5):365-72.

PMID:
2209169
11.

Antimicrobial properties of natural coniferous rosin in the European Pharmacopoeia challenge test.

Sipponen A, Laitinen K.

APMIS. 2011 Oct;119(10):720-4. doi: 10.1111/j.1600-0463.2011.02791.x. Epub 2011 Jul 18.

PMID:
21917009
12.

The antimicrobial activity of inert oligonuclear polypyridylruthenium(II) complexes against pathogenic bacteria, including MRSA.

Li F, Mulyana Y, Feterl M, Warner JM, Collins JG, Keene FR.

Dalton Trans. 2011 May 14;40(18):5032-8. doi: 10.1039/c1dt10250h. Epub 2011 Mar 28.

PMID:
21442118
13.
14.

Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.

Cole EC, Addison RM, Rubino JR, Leese KE, Dulaney PD, Newell MS, Wilkins J, Gaber DJ, Wineinger T, Criger DA.

J Appl Microbiol. 2003;95(4):664-76.

15.
16.

In vitro antibacterial activities of FK037: a new parenteral cephalosporin.

Inoue K, Inoue E, Mitsuhashi S.

Chemotherapy. 1995 Jul-Aug;41(4):257-66.

PMID:
7555206
17.

In vitro antibacterial activity of E-101 Solution, a novel myeloperoxidase-mediated antimicrobial, against Gram-positive and Gram-negative pathogens.

Denys GA, Grover P, O'Hanley P, Stephens JT Jr.

J Antimicrob Chemother. 2011 Feb;66(2):335-42. doi: 10.1093/jac/dkq429. Epub 2010 Nov 30.

PMID:
21118915
18.

Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study.

Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller LA, Poupard JA; Gemifloxacin Surveillance Study Research Group.

Diagn Microbiol Infect Dis. 2001 May-Jun;40(1-2):51-7.

PMID:
11448564
19.

Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.

McKay GA, Beaulieu S, Arhin FF, Belley A, Sarmiento I, Parr T Jr, Moeck G.

J Antimicrob Chemother. 2009 Jun;63(6):1191-9. doi: 10.1093/jac/dkp126. Epub 2009 Apr 15.

PMID:
19369269
20.

Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.

Mascellino MT, Farinelli S, Iegri F, Iona E, De Simone C.

Drugs Exp Clin Res. 1998;24(3):139-51.

PMID:
9825230

Supplemental Content

Support Center